-
As of today ICMag has his own Discord server. In this Discord server you can chat, talk with eachother, listen to music, share stories and pictures...and much more. Join now and let's grow together! Join ICMag Discord here! More details in this thread here: here.
:::::::Indiana Cannabis Reform Legislation::::::
- Thread starter pipeline
- Start date
Take time to review the federal and state bills/legislation that have been introduced. Pick the bills you like the most, make note of ways it can be improved, and contact your legislators. Tell them to support those bills, and let them know the changes you'd like to see and why.
Also can send pre-written letters of support of legislation here
We can't settle for this medical cannabis with Doctor's permission only, when in fact this plant is valuable medicine for everyone even with minor health issues, or just people who want to promote health and wellbeing. Cannabis is for everyone.
Legalize adult-use cannabis! We can't settle for some medical cannabis control program which seeks to harm us.
Legalize adult-use cannabis! We can't settle for some medical cannabis control program which seeks to harm us.
Exempt veterans from paying sales tax. What is this nonsense? They are junking up these bills.
Congressman Delivers ‘Angry’ Floor Speech About Stalled Federal Marijuana Reform, But Says It’s ‘Not Too Late’ To Act
It’s “not too late” for the current Congress to pass sensible marijuana reform legislation and end the “insane” prohibitionist policies of the war on drugs, Rep. Earl Blumenauer (D-OR) says. In an impassioned speech on the House floor on Thursday, the founding member of the Congressional...
www.marijuanamoment.net
It’s “not too late” for the current Congress to pass sensible marijuana reform legislation and end the “insane” prohibitionist policies of the war on drugs, Rep. Earl Blumenauer (D-OR) says.
In an impassioned speech on the House floor on Thursday, the founding member of the Congressional Cannabis Caucus said he is both “sad” and “angry” over the continued federal inaction on marijuana reform, arguing that it’s “time for Congress to stop making this problem worse.”
“I’ve been working for 50 years leading the effort to end the failed, unfair, cynical, dangerous war on drugs that targeted Black people, that discouraged the illegal use of a therapeutic good—something that could have enriched our economy but instead criminalized behavior,” he said.
Blumenauer, who is retiring at the end of this year but still plans to be involved in advancing the issue, said members have seen stories about the potential harms of cannabis for vulnerable populations—but that’s precisely why they should support a legal regulatory framework to mitigate risks.
“We don’t have a system that regulates it, that taxes it, that keeps it out of the hands of children,” he said. “No neighborhood drug dealer looks for identification, and they’re perfectly happy to sell kids other more dangerous and potent drugs. We don’t have to do this.”
Congressional Researchers Detail Limitations Of Marijuana Rescheduling For State Markets And Criminal Justice Reform
As the Drug Enforcement Administration (DEA) weighs a marijuana rescheduling recommendation from health officials, congressional researchers are laying out the limitations of the policy change— emphasizing that state cannabis markets would continue to run afoul of federal law, and existing...
Congressional Researchers Detail Limitations Of Marijuana Rescheduling For State Markets And Criminal Justice Reform
January 16, 2024
By
Kyle Jaeger
As the Drug Enforcement Administration (DEA) weighs a marijuana rescheduling recommendation from health officials, congressional researchers are laying out the limitations of the policy change— emphasizing that state cannabis markets would continue to run afoul of federal law, and existing criminal penalties for certain marijuana-related activity would remain in force.
In a report published on Tuesday, the Congressional Research Service (CRS) explained the “legal consequences” of moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), as the U.S. Department of Health and Human Services (HHS) has advised DEA to do following its comprehensive scientific review.
“Moving marijuana from Schedule I to Schedule III, without other legal changes, would not bring the state-legal medical or recreational marijuana industry into compliance with federal controlled substances law,” CRS said.
“With respect to medical marijuana, a key difference between placement in Schedule I and Schedule III is that substances in Schedule III have an accepted medical use and may lawfully be dispensed by prescription, while Substances in Schedule I cannot,” it continued. However, in order for marijuana to be legally prescribed, the Food and Drug Administration (FDA) would need to approve its use, and plant medicines do not typically go through that approval process.
“Moreover, if one or more marijuana products obtained FDA approval, manufacturers and distributors would need to register with DEA and comply with regulatory requirements that apply to Schedule III substances in order to handle those products. Users of medical marijuana would need to obtain valid prescriptions for the substance from medical providers, subject to federal legal requirements that differ from existing state regulatory requirements for medical marijuana.”
Importantly, the report explains that only certain criminal penalties “depend on the schedule in which a substance is classified,” while others are specific to marijuana and would not automatically change with a Schedule III reclassification.
“If marijuana were moved to Schedule III, applicable penalties for some offenses would be reduced,” it says. “However, CSA penalties that apply to activities involving marijuana specifically, such as the quantity-based mandatory minimum sentences discussed above, would not change as a result of rescheduling.”
CRS did point out, however, that the scheduling change would “allow marijuana businesses to deduct business expenses on federal tax filings” that they’ve been barred from under an Internal Revenue Service (IRS) code known as 280E.
“Other collateral legal consequences would continue to attach to unauthorized marijuana-related activities,” the report says.
Regardless of what scheduling decision is ultimately made, CRS said the Justice Department would continue to be blocked from interfering in state medical cannabis programs under an appropriations rider that Congress has annually renewed each year since 2014.
“Thus, so long as the current rider remains in effect, participants in the state-legal medical marijuana industry who comply with state law would be shielded from federal prosecution,” the report says. “If the rider were to lapse or be repealed, these persons would again be subject to prosecution at the discretion of DOJ.”
The researchers also offered considerations for Congress, stating that if lawmakers want to change the legal status of marijuana “it has broad authority to do so before or after DEA makes any scheduling decision.” It listed a number of existing legislative proposals that “would relax federal regulation of marijuana,” while noting that “Congress could also seek to impose more stringent controls.”
“Rescheduling or descheduling marijuana under the CSA could raise additional legal questions,” it continues. “For instance, FDA regulates certain cannabis products under the Federal Food, Drug, and Cosmetic Act, so Congress might also consider whether to alter that regulatory regime or create some alternative regulatory framework. In addition, relaxing the CSA’s restrictions on marijuana could implicate the United States’ international treaty obligations.”
In September, CRS released a related analysis that focused on how rescheduling would have “broad implications for federal policy” in areas such as taxes, housing, immigration, military eligibility, gun rights and more. Researchers also assessed that it is “likely” DEA will abide by the HHS recommendation, based on past precedent.
HHS finally released the full recommendation and scientific findings it shared with DEA last week, and HHS Secretary Xavier Becerra said his agency has “communicated” their “position” on marijuana rescheduling to DEA and has continued to offer additional information to assist with the final determination.
As CRS said in its new report, DEA has steadfastly maintained it has “final authority” over the matter and can make any scheduling determination that it sees fit.
“DEA has the final authority to schedule, reschedule, or deschedule a drug under the Controlled Substances Act, after considering the relevant statutory and regulatory criteria and HHS’s scientific and medical evaluation,” the agency said in a letter to lawmakers last month. “DEA is now conducting its review.”
The statement came in response to an earlier letter from 31 bipartisan lawmakers, led by Rep. Earl Blumenauer (D-OR), that urged the agency to consider the “merits” of legalization as it carried out its review.
DEA has faced pressure on both sides of the marijuana policy debate over recent months, with advocates pressing for a Schedule III decision, or complete descheduling, and prohibitionists urging the agency to keep cannabis in Schedule I.
Prior to the HHS documents’ release, a coalition of 12 Democratic state attorneys general implored DEA to move forward with federal marijuana rescheduling, calling the policy change a “public safety imperative.”
In another letter last month, 29 former U.S. attorneys called on the Biden administration to leave cannabis in Schedule I.
Last month, the governors of six U.S. states—Colorado, Illinois, New York, New Jersey, Maryland and Louisiana—sent a letter to Biden calling on the administration to reschedule marijuana by the end of last year.
Meanwhile, six former DEA heads and five former White House drug czars sent a letter to the attorney general and current DEA administrator voicing opposition to the top federal health agency’s recommendation to reschedule marijuana. They also made a questionable claim about the relationship between drug schedules and criminal penalties in a way that could exaggerate the potential impact of the incremental reform.
Signatories include DEA and Office of National Drug Control Policy heads under multiple administrations led by presidents of both major parties.
In October, Advocates and lawmakers who support cannabis reform marked the one-year anniversary of Biden’s mass marijuana pardon and scheduling directive this month by calling on him to do more—including by expanding the scope of relief that his pardon had and by expressly supporting federal legalization.
Two GOP senators, including the lead Republican sponsor of a marijuana banking bill that cleared a key committee in September, also filed legislation late last year to prevent federal agencies from rescheduling cannabis without tacit approval from Congress.
A coalition of 14 Republican congressional lawmakers, meanwhile, has urged DEA to “reject” the top federal health agency’s recommendation to reschedule marijuana and instead keep it in the most restrictive category under the CSA.
you do realize, i hope, that amendments like helping veterans make it easier for the undecided general public to support the bill? NO medical user should be paying tax, in my opinion.
Justice Department Researcher Questions 0.3% THC Limit For Hemp, Saying Federal Law Based On 1950s Anecdote
A person would need to “smoke a joint the size of a telephone pole” to get high from hemp, even if it marginally exceeds the 0.3 percent THC threshold that separates the federally legal crop from prohibited marijuana, a Justice Department researcher says. It’s part of what makes the federal...
www.marijuanamoment.net
Indiana Senate Panel Unanimously Passes Psilocybin Research Bill With Minor Amendments
Indiana’s Senate Health and Provider Services Committee on Wednesday unanimously approved a bill that would fund clinical research trials into psilocybin, making two relatively minor amendments before advancing the legislation. “There’s reason to believe that there is value in psilocybin and, at...
www.marijuanamoment.net
The state legislative committee that heard the first cannabis bill in state history last year with minimal discussion and no vote.
There was an interem study committee which looked at cannabis, but it was minimal discussion and there was no vote held on a specific bill because it was out of session.
Last edited:
Marijuana Advocates Plan ‘Largest Bipartisan’ Push For Federal Reform At Pre-4/20 Event In D.C. As Rescheduling Decision Looms
A leading cannabis group is planning to mobilize the “largest bi-partisan coalition of cannabis advocacy, industry, and grassroots organizations” that will convene in Washington, D.C. to push for federal reform just ahead of the marijuana holiday 4/20 this year. Organized by the Last Prisoner...
www.marijuanamoment.net
Congressional Committee had no problem hearing and passing this bill to investigate Psilosybin as a therapeutic. Cannabis bills never received a hearing with a vote. Cannabis is not being studies for its therapeutic value, when cannabis has been an issue that has been a focus of medical needs of a much greater number of people for decades.
Why did the committee pass this SB 1039 bill with no problem, but were unable to discuss and vote on a cannabis bill????? I wonder, but I can understand the level of corruption and cowardice going on here among our legislative representatives.
Why did the committee pass this SB 1039 bill with no problem, but were unable to discuss and vote on a cannabis bill????? I wonder, but I can understand the level of corruption and cowardice going on here among our legislative representatives.
American Nurses Association Cheers Federal Health Agency’s Marijuana Rescheduling Recommendation
The American Nurses Association is applauding the U.S. Department of Health and Human Services’s (HHS) recommendation to move marijuana to Schedule III, calling the action “a positive step toward developing an evidence-based approach for marijuana and related-cannabinoids use in disease and...
www.marijuanamoment.net
Nikki Haley Says She Will ‘Go With The Scientists’ On Federal Marijuana Rescheduling, Saying It ‘Obviously’ Doesn’t Belong In Same Class As Heroin
Former South Carolina Gov. Nikki Haley (R), a GOP 2024 presidential candidate, says she agrees with federal health officials in the Biden administration that marijuana should be rescheduled, stating that cannabis “obviously” doesn’t belong in the same category as heroin. During a town hall event...
www.marijuanamoment.net
Marianne Williamson Accuses Congressional Lawmakers Of Using Drugs And Slams ‘Hypocrisy’ Of Delayed Marijuana Reform
Marianne Williamson, a 2024 Democratic presidential candidate, sharply criticized the Biden administration and Congress for slow-walking marijuana reform, accusing lawmakers of “hypocrisy” for failing to legalize cannabis at the same time that they’re privately using illegal drugs. At a campaign...
www.marijuanamoment.net
https://www.msn.com/en-us/news/poli...e-survey-has-the-pulse-of-indiana/ar-AA1n86o3 --Click here for link to story held on MSN website
Do Hoosiers want legal abortion, marijuana? One survey has 'the pulse' of Indiana
Story by Chris Sims, Indianapolis Star • 3d
GOP-Backed Bill in Indiana Would Create Fund To Study Shrooms
A proposed bill offered up by a Republican lawmaker in Indiana would open the door for the state to research psilocybin, the psychedelic compound in “magic mushrooms.”
hightimes.com
HIGHTIMES.com
wanting abortion to be safe, legal, and available if it is needed is crucial for women's health. likewise, many that want cannabis legal are not smokers, nor will they ever be. damn few legislators that get this, i'm afraid. 
Its kind of a blessing and a curse having these 2 issues put out for the public at the same time. I think that makes it easier to look at the issues for some people. It also works to dilute the conversation and derail the main issues which need to be debated.
Can anyone say, puppet show?
Can anyone say, puppet show?
or "goat roping" ?
